EU Approvals

AVVA Pharmaceuticals Ltd announces the submission of Micrazym (pancrealipase modified release micropellets in capsules) in 16 EU Countries, making AVVA the third supplier Worldwide doing so.

Read More

AVVA Pharmaceuticals Ltd Awarded with a EUROSTARS Edit

AVVA has been awarded with a Eurostars funded research programme by the European Commission under Horizon 2020. The award has been received for the research and development of an innovative product for the treatment of H. Pylori infection, Lactomezole.

Read More

EU Approvals

AVVA Pharmaceuticals Ltd announces the first two EU file submissions for Lactofiltrum and Filtrum. Filtrum and Lactofiltrum are the first in class lignin based products to be submitted to EU medical device competent authorities.

Read More